Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty
Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of...
Gespeichert in:
Veröffentlicht in: | Endocrine 2004-03, Vol.23 (2-3), p.189-198 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 198 |
---|---|
container_issue | 2-3 |
container_start_page | 189 |
container_title | Endocrine |
container_volume | 23 |
creator | Olivares, A Söderlund, D Castro-Fernández, C Zariñán, T Zambrano, Elena Méndez, J P Ulloa-Aguirre, A |
description | Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of sample collection. In the present study, we attempted to define the impact of the changing endocrine milieu characteristic of male puberty on the charge heterogeneity and plasma half-life of the serum FSH isoforms released under endogenous and exogenous GnRH drives, and examined whether such a varying hormone milieu modifies the capability of the circulating hormone to trigger intracellular signal transduction at the human FSH receptor level. Forty healthy male subjects at Tanner stages (Ts) 1 to 5 were sampled at 10 min intervals for 10 h. Serum from successive samples collected across 2-4 h intervals containing FSH released under basal, low-dose (10 microg), and high-dose (90 microg) exogenous GnRH-stimulated conditions was subjected to preparative chromatofocusing and tested for bioactivity employing a homologous cell in vitro bioassay system. Deconvolution analysis was applied to estimate the apparent endogenous FSH plasma half-life in samples obtained after administration of low-dose exogenous GnRH. Under all conditions studied, serum FSH charge isoforms were distributed along a pH range of 7.0 to less than 3.0. Comparisons across the different Tanner stages revealed a significant and selective increase in the ratio of FSH isoforms with elution pH values /=4.50 at Ts-2. At Ts-3, this ratio returned to that present at Ts-1, to decline thereafter during the ensuing pubertal stages. Serum bioactive FSH concentrations progressively increased (from 3.72 +/- 1.3 to 16.2 +/- 5.3 IU/L) throughout puberty, and in all conditions bioactive FSH concentrations exceeded those detected by a specific radioimmunoassay. The biological to immunological (B:I) FSH ratio at baseline was significantly (p < 0.05) lower at Ts-1 and Ts-2 (1.33 +/- 0.30 and 1.62 +/- 0.34, respectively) than at more advanced stages of pubertal development (2.28 +/- 0.20, 2.96 +/- 0.38, and 2.77 +/- 0.63 at Ts-3-, 4-, and -5, respectively) Similar differences were detected in samples containing FSH molecules released after low- and high-dose GnRH administration. The apparent endogenous FSH half-life of the deconvolved GnRH-induced FSH pulses was similar in the five |
doi_str_mv | 10.1385/ENDO:23:2-3:189 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2664866895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2664866895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-b427243c683d9dd835acd175b906239189247cbd1d9d885dc8404d7f492b44343</originalsourceid><addsrcrecordid>eNpNkU1rFDEAhoModls9e5OA59h8TSazN621CsVeFHoL-ZptSiZZk0yhP8t_aNau6Cnw5sn7QF4A3hD8njA5nF9--3SzpWxLEdsSOT0DGzyJCY2E3D4HG8KGAWEsb0_Aaa33GFNKxfgSnJCBcEEw3oBfH3XVEerk4C4n7XIreR8SKj56XUPawbtclpz8MdEmelh9WRc45xiDjR7VFpY16vYfDe2dLjsPQ81zT6ALtZVg1hZy-iMLCT6E7oIm5Jh3weqIWkZhWdb0N4Cld-YDuuhu3a_Gl_b4CryYdaz-9fE8Az8-X36_-IKub66-Xny4RpZR0pDhdKScWSGZm5yTbNDWkXEwExaUTf2zKB-tcaTfSjk4Kznmbpz5RA3njLMz8O6pd1_yz9XXpu7zWlJXKioEl0LIaejU-RNlS661-FntS1h0eVQEq8NE6jCRokxRxVS39hdvj72rWbz7xx83Yb8BpRWRiw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2664866895</pqid></control><display><type>article</type><title>Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Olivares, A ; Söderlund, D ; Castro-Fernández, C ; Zariñán, T ; Zambrano, Elena ; Méndez, J P ; Ulloa-Aguirre, A</creator><creatorcontrib>Olivares, A ; Söderlund, D ; Castro-Fernández, C ; Zariñán, T ; Zambrano, Elena ; Méndez, J P ; Ulloa-Aguirre, A</creatorcontrib><description>Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of sample collection. In the present study, we attempted to define the impact of the changing endocrine milieu characteristic of male puberty on the charge heterogeneity and plasma half-life of the serum FSH isoforms released under endogenous and exogenous GnRH drives, and examined whether such a varying hormone milieu modifies the capability of the circulating hormone to trigger intracellular signal transduction at the human FSH receptor level. Forty healthy male subjects at Tanner stages (Ts) 1 to 5 were sampled at 10 min intervals for 10 h. Serum from successive samples collected across 2-4 h intervals containing FSH released under basal, low-dose (10 microg), and high-dose (90 microg) exogenous GnRH-stimulated conditions was subjected to preparative chromatofocusing and tested for bioactivity employing a homologous cell in vitro bioassay system. Deconvolution analysis was applied to estimate the apparent endogenous FSH plasma half-life in samples obtained after administration of low-dose exogenous GnRH. Under all conditions studied, serum FSH charge isoforms were distributed along a pH range of 7.0 to less than 3.0. Comparisons across the different Tanner stages revealed a significant and selective increase in the ratio of FSH isoforms with elution pH values <4.50 relative to those with values >/=4.50 at Ts-2. At Ts-3, this ratio returned to that present at Ts-1, to decline thereafter during the ensuing pubertal stages. Serum bioactive FSH concentrations progressively increased (from 3.72 +/- 1.3 to 16.2 +/- 5.3 IU/L) throughout puberty, and in all conditions bioactive FSH concentrations exceeded those detected by a specific radioimmunoassay. The biological to immunological (B:I) FSH ratio at baseline was significantly (p < 0.05) lower at Ts-1 and Ts-2 (1.33 +/- 0.30 and 1.62 +/- 0.34, respectively) than at more advanced stages of pubertal development (2.28 +/- 0.20, 2.96 +/- 0.38, and 2.77 +/- 0.63 at Ts-3-, 4-, and -5, respectively) Similar differences were detected in samples containing FSH molecules released after low- and high-dose GnRH administration. The apparent endogenous FSH half-life of the deconvolved GnRH-induced FSH pulses was similar in the five study groups. These results demonstrate that the transition from infancy to sexual maturity in men is accompanied by qualitative changes in the circulating FSH isoform mixture. Although the changes in FSH glycosylation occurring throughout puberty are not of sufficient magnitude to alter the survival of the gonadotropin in circulation, they allow preferential secretion of bioactive FSH. The enrichment of the circulating mix of FSH isoforms with highly bioactive variants throughout spontaneous puberty may potentially favor the development of spermatogenesis and acquisition of reproductive competence.</description><identifier>ISSN: 1355-008X</identifier><identifier>ISSN: 0969-711X</identifier><identifier>EISSN: 0969-711X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1385/ENDO:23:2-3:189</identifier><identifier>PMID: 15146100</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adolescent ; Adult ; Biological activity ; Biological Assay ; Cell Line ; Child ; Chromatofocusing ; Developmental stages ; Dose-Response Relationship, Drug ; Endocrinology ; Estradiol - blood ; Follicle Stimulating Hormone - blood ; Follicle Stimulating Hormone - metabolism ; Follicle-stimulating hormone ; Glycosylation ; Gonadotropin-releasing hormone ; Gonadotropin-Releasing Hormone - administration & dosage ; Gonadotropins ; Gonadotropins - blood ; Half-Life ; Humans ; Hydrogen-Ion Concentration ; Immunology ; Isoforms ; Male ; pH effects ; Pituitary (anterior) ; Protein Isoforms - blood ; Puberty ; Puberty - blood ; Radioimmunoassay ; Sexual maturity ; Signal transduction ; Spermatogenesis ; Testosterone - blood</subject><ispartof>Endocrine, 2004-03, Vol.23 (2-3), p.189-198</ispartof><rights>Copyright 2004 Humana Press Inc.</rights><rights>Humana Press Inc. 2004.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-b427243c683d9dd835acd175b906239189247cbd1d9d885dc8404d7f492b44343</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15146100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olivares, A</creatorcontrib><creatorcontrib>Söderlund, D</creatorcontrib><creatorcontrib>Castro-Fernández, C</creatorcontrib><creatorcontrib>Zariñán, T</creatorcontrib><creatorcontrib>Zambrano, Elena</creatorcontrib><creatorcontrib>Méndez, J P</creatorcontrib><creatorcontrib>Ulloa-Aguirre, A</creatorcontrib><title>Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty</title><title>Endocrine</title><addtitle>Endocrine</addtitle><description>Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of sample collection. In the present study, we attempted to define the impact of the changing endocrine milieu characteristic of male puberty on the charge heterogeneity and plasma half-life of the serum FSH isoforms released under endogenous and exogenous GnRH drives, and examined whether such a varying hormone milieu modifies the capability of the circulating hormone to trigger intracellular signal transduction at the human FSH receptor level. Forty healthy male subjects at Tanner stages (Ts) 1 to 5 were sampled at 10 min intervals for 10 h. Serum from successive samples collected across 2-4 h intervals containing FSH released under basal, low-dose (10 microg), and high-dose (90 microg) exogenous GnRH-stimulated conditions was subjected to preparative chromatofocusing and tested for bioactivity employing a homologous cell in vitro bioassay system. Deconvolution analysis was applied to estimate the apparent endogenous FSH plasma half-life in samples obtained after administration of low-dose exogenous GnRH. Under all conditions studied, serum FSH charge isoforms were distributed along a pH range of 7.0 to less than 3.0. Comparisons across the different Tanner stages revealed a significant and selective increase in the ratio of FSH isoforms with elution pH values <4.50 relative to those with values >/=4.50 at Ts-2. At Ts-3, this ratio returned to that present at Ts-1, to decline thereafter during the ensuing pubertal stages. Serum bioactive FSH concentrations progressively increased (from 3.72 +/- 1.3 to 16.2 +/- 5.3 IU/L) throughout puberty, and in all conditions bioactive FSH concentrations exceeded those detected by a specific radioimmunoassay. The biological to immunological (B:I) FSH ratio at baseline was significantly (p < 0.05) lower at Ts-1 and Ts-2 (1.33 +/- 0.30 and 1.62 +/- 0.34, respectively) than at more advanced stages of pubertal development (2.28 +/- 0.20, 2.96 +/- 0.38, and 2.77 +/- 0.63 at Ts-3-, 4-, and -5, respectively) Similar differences were detected in samples containing FSH molecules released after low- and high-dose GnRH administration. The apparent endogenous FSH half-life of the deconvolved GnRH-induced FSH pulses was similar in the five study groups. These results demonstrate that the transition from infancy to sexual maturity in men is accompanied by qualitative changes in the circulating FSH isoform mixture. Although the changes in FSH glycosylation occurring throughout puberty are not of sufficient magnitude to alter the survival of the gonadotropin in circulation, they allow preferential secretion of bioactive FSH. The enrichment of the circulating mix of FSH isoforms with highly bioactive variants throughout spontaneous puberty may potentially favor the development of spermatogenesis and acquisition of reproductive competence.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological activity</subject><subject>Biological Assay</subject><subject>Cell Line</subject><subject>Child</subject><subject>Chromatofocusing</subject><subject>Developmental stages</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endocrinology</subject><subject>Estradiol - blood</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Follicle Stimulating Hormone - metabolism</subject><subject>Follicle-stimulating hormone</subject><subject>Glycosylation</subject><subject>Gonadotropin-releasing hormone</subject><subject>Gonadotropin-Releasing Hormone - administration & dosage</subject><subject>Gonadotropins</subject><subject>Gonadotropins - blood</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Immunology</subject><subject>Isoforms</subject><subject>Male</subject><subject>pH effects</subject><subject>Pituitary (anterior)</subject><subject>Protein Isoforms - blood</subject><subject>Puberty</subject><subject>Puberty - blood</subject><subject>Radioimmunoassay</subject><subject>Sexual maturity</subject><subject>Signal transduction</subject><subject>Spermatogenesis</subject><subject>Testosterone - blood</subject><issn>1355-008X</issn><issn>0969-711X</issn><issn>0969-711X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkU1rFDEAhoModls9e5OA59h8TSazN621CsVeFHoL-ZptSiZZk0yhP8t_aNau6Cnw5sn7QF4A3hD8njA5nF9--3SzpWxLEdsSOT0DGzyJCY2E3D4HG8KGAWEsb0_Aaa33GFNKxfgSnJCBcEEw3oBfH3XVEerk4C4n7XIreR8SKj56XUPawbtclpz8MdEmelh9WRc45xiDjR7VFpY16vYfDe2dLjsPQ81zT6ALtZVg1hZy-iMLCT6E7oIm5Jh3weqIWkZhWdb0N4Cld-YDuuhu3a_Gl_b4CryYdaz-9fE8Az8-X36_-IKub66-Xny4RpZR0pDhdKScWSGZm5yTbNDWkXEwExaUTf2zKB-tcaTfSjk4Kznmbpz5RA3njLMz8O6pd1_yz9XXpu7zWlJXKioEl0LIaejU-RNlS661-FntS1h0eVQEq8NE6jCRokxRxVS39hdvj72rWbz7xx83Yb8BpRWRiw</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>Olivares, A</creator><creator>Söderlund, D</creator><creator>Castro-Fernández, C</creator><creator>Zariñán, T</creator><creator>Zambrano, Elena</creator><creator>Méndez, J P</creator><creator>Ulloa-Aguirre, A</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20040301</creationdate><title>Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty</title><author>Olivares, A ; Söderlund, D ; Castro-Fernández, C ; Zariñán, T ; Zambrano, Elena ; Méndez, J P ; Ulloa-Aguirre, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-b427243c683d9dd835acd175b906239189247cbd1d9d885dc8404d7f492b44343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological activity</topic><topic>Biological Assay</topic><topic>Cell Line</topic><topic>Child</topic><topic>Chromatofocusing</topic><topic>Developmental stages</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endocrinology</topic><topic>Estradiol - blood</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Follicle Stimulating Hormone - metabolism</topic><topic>Follicle-stimulating hormone</topic><topic>Glycosylation</topic><topic>Gonadotropin-releasing hormone</topic><topic>Gonadotropin-Releasing Hormone - administration & dosage</topic><topic>Gonadotropins</topic><topic>Gonadotropins - blood</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Immunology</topic><topic>Isoforms</topic><topic>Male</topic><topic>pH effects</topic><topic>Pituitary (anterior)</topic><topic>Protein Isoforms - blood</topic><topic>Puberty</topic><topic>Puberty - blood</topic><topic>Radioimmunoassay</topic><topic>Sexual maturity</topic><topic>Signal transduction</topic><topic>Spermatogenesis</topic><topic>Testosterone - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olivares, A</creatorcontrib><creatorcontrib>Söderlund, D</creatorcontrib><creatorcontrib>Castro-Fernández, C</creatorcontrib><creatorcontrib>Zariñán, T</creatorcontrib><creatorcontrib>Zambrano, Elena</creatorcontrib><creatorcontrib>Méndez, J P</creatorcontrib><creatorcontrib>Ulloa-Aguirre, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olivares, A</au><au>Söderlund, D</au><au>Castro-Fernández, C</au><au>Zariñán, T</au><au>Zambrano, Elena</au><au>Méndez, J P</au><au>Ulloa-Aguirre, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty</atitle><jtitle>Endocrine</jtitle><addtitle>Endocrine</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>23</volume><issue>2-3</issue><spage>189</spage><epage>198</epage><pages>189-198</pages><issn>1355-008X</issn><issn>0969-711X</issn><eissn>0969-711X</eissn><eissn>1559-0100</eissn><abstract>Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of sample collection. In the present study, we attempted to define the impact of the changing endocrine milieu characteristic of male puberty on the charge heterogeneity and plasma half-life of the serum FSH isoforms released under endogenous and exogenous GnRH drives, and examined whether such a varying hormone milieu modifies the capability of the circulating hormone to trigger intracellular signal transduction at the human FSH receptor level. Forty healthy male subjects at Tanner stages (Ts) 1 to 5 were sampled at 10 min intervals for 10 h. Serum from successive samples collected across 2-4 h intervals containing FSH released under basal, low-dose (10 microg), and high-dose (90 microg) exogenous GnRH-stimulated conditions was subjected to preparative chromatofocusing and tested for bioactivity employing a homologous cell in vitro bioassay system. Deconvolution analysis was applied to estimate the apparent endogenous FSH plasma half-life in samples obtained after administration of low-dose exogenous GnRH. Under all conditions studied, serum FSH charge isoforms were distributed along a pH range of 7.0 to less than 3.0. Comparisons across the different Tanner stages revealed a significant and selective increase in the ratio of FSH isoforms with elution pH values <4.50 relative to those with values >/=4.50 at Ts-2. At Ts-3, this ratio returned to that present at Ts-1, to decline thereafter during the ensuing pubertal stages. Serum bioactive FSH concentrations progressively increased (from 3.72 +/- 1.3 to 16.2 +/- 5.3 IU/L) throughout puberty, and in all conditions bioactive FSH concentrations exceeded those detected by a specific radioimmunoassay. The biological to immunological (B:I) FSH ratio at baseline was significantly (p < 0.05) lower at Ts-1 and Ts-2 (1.33 +/- 0.30 and 1.62 +/- 0.34, respectively) than at more advanced stages of pubertal development (2.28 +/- 0.20, 2.96 +/- 0.38, and 2.77 +/- 0.63 at Ts-3-, 4-, and -5, respectively) Similar differences were detected in samples containing FSH molecules released after low- and high-dose GnRH administration. The apparent endogenous FSH half-life of the deconvolved GnRH-induced FSH pulses was similar in the five study groups. These results demonstrate that the transition from infancy to sexual maturity in men is accompanied by qualitative changes in the circulating FSH isoform mixture. Although the changes in FSH glycosylation occurring throughout puberty are not of sufficient magnitude to alter the survival of the gonadotropin in circulation, they allow preferential secretion of bioactive FSH. The enrichment of the circulating mix of FSH isoforms with highly bioactive variants throughout spontaneous puberty may potentially favor the development of spermatogenesis and acquisition of reproductive competence.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>15146100</pmid><doi>10.1385/ENDO:23:2-3:189</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-008X |
ispartof | Endocrine, 2004-03, Vol.23 (2-3), p.189-198 |
issn | 1355-008X 0969-711X 0969-711X 1559-0100 |
language | eng |
recordid | cdi_proquest_journals_2664866895 |
source | MEDLINE; SpringerLink Journals |
subjects | Adolescent Adult Biological activity Biological Assay Cell Line Child Chromatofocusing Developmental stages Dose-Response Relationship, Drug Endocrinology Estradiol - blood Follicle Stimulating Hormone - blood Follicle Stimulating Hormone - metabolism Follicle-stimulating hormone Glycosylation Gonadotropin-releasing hormone Gonadotropin-Releasing Hormone - administration & dosage Gonadotropins Gonadotropins - blood Half-Life Humans Hydrogen-Ion Concentration Immunology Isoforms Male pH effects Pituitary (anterior) Protein Isoforms - blood Puberty Puberty - blood Radioimmunoassay Sexual maturity Signal transduction Spermatogenesis Testosterone - blood |
title | Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A50%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Basal%20and%20gonadotropin-releasing%20hormone-releasable%20serum%20follicle-stimulating%20hormone%20charge%20isoform%20distribution%20and%20in%20vitro%20biological-to-immunological%20ratio%20in%20male%20puberty&rft.jtitle=Endocrine&rft.au=Olivares,%20A&rft.date=2004-03-01&rft.volume=23&rft.issue=2-3&rft.spage=189&rft.epage=198&rft.pages=189-198&rft.issn=1355-008X&rft.eissn=0969-711X&rft_id=info:doi/10.1385/ENDO:23:2-3:189&rft_dat=%3Cproquest_cross%3E2664866895%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2664866895&rft_id=info:pmid/15146100&rfr_iscdi=true |